Everence Capital Management’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$254K	Sell	3,853 -227	-6%	-$14.4K	0.02%	656
2025 Q4	$259K	Hold	4,080	–	–	0.02%	651
2025 Q3	$224K	Buy	+4,080	New	+$168K	0.01%	727
2024 Q1	–	Sell	-13,510	Closed	-$1.13M	–	763
2023 Q4	$1.13M	Hold	13,510	–	–	0.08%	206
2023 Q3	$398	Sell	13,510 -2,940	-18%	-$97.9K	0.03%	454
2023 Q2	$620K	Hold	16,450	–	–	0.05%	304
2023 Q1	$579	Hold	16,450	–	–	0.05%	326
2022 Q4	$754	Hold	16,450	–	–	0.07%	259
2022 Q3	$797K	Hold	16,450	–	–	0.07%	233
2022 Q2	$646K	Buy	16,450 +2,550	+18%	+$103K	0.06%	264
2022 Q1	$512K	Hold	13,900	–	–	0.04%	385
2021 Q4	$634K	Hold	13,900	–	–	0.05%	338
2021 Q3	$497K	Buy	13,900 +3,700	+36%	+$109K	0.04%	405
2021 Q2	$202K	Hold	10,200	–	–	0.02%	699
2021 Q1	$237K	Sell	10,200 -4,710	-32%	-$101K	0.02%	637
2020 Q4	$310K	Hold	14,910	–	–	0.03%	504
2020 Q3	$323K	Sell	14,910 -1,470	-9%	-$34.4K	0.04%	436
2020 Q2	$339K	Hold	16,380	–	–	0.04%	417
2020 Q1	$193K	Hold	16,380	–	–	0.03%	522
2019 Q4	$174K	Hold	16,380	–	–	0.03%	633
2019 Q3	$186K	Hold	16,380	–	–	0.03%	584
2019 Q2	$184K	Hold	16,380	–	–	0.03%	585
2019 Q1	$133K	Buy	+16,380	New	+$120K	0.02%	602